TrialReader


The Italian Registry of Malnutrition in Oncology

NCT06337019 — Recruiting, 1500 participants, Fondazione IRCCS Policlinico San Matteo di Pavia

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Multicentric, Observational, Longitudinal Study for the Evaluation of Nutritional Management Implications in Newly Diagnosed Italian Cancer Patients: The Italian Registry of Malnutrition in Oncology (IRMO)

RegistryNCT06337019, acronym IRMO
StatusRecruiting
Study typeObservational
Enrollment1500 (Estimated)
SponsorFondazione IRCCS Policlinico San Matteo di Pavia (Other); collaborators: Istituto Di Ricerche Farmacologiche Mario Negri
ConditionsCancer, Cancer Metastatic
InterventionsCohort observational (Other)
Datesstart 2022-10-25, primary completion 2027-10-01 (estimated), completion 2027-10-01 (estimated), first posted 2024-03-29, last updated 2024-04-03
Locations16 sites in Italy

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Cancer All trials for Cancer Metastatic All trials of Cohort observational

-Summary

The aim of the Italian Registry of Malnutrition in Oncology (IRMO) is to set up a digital register of newly diagnosed or treated oncologic patients to monitor their nutritional status, early identify malnutrition and investigate the implications of nutritional support management. In particular, this project aims to establish a prospective cohort of cancer patients in order to investigate the effects of nutritional status and management on overall survival (OS) and progression free survival (PFS), and analyse the effects of the nutritional management and support on patients' symptoms and QoL.

Expand all sections  ·  Collapse all

+Detailed description

This is a multicentric longitudinal observational study on a cohort of newly diagnosed cancer patients, candidate for active treatment. In Italy, no reliable data are still available with regards to the actual implementation of adequate nutritional support management in cancer patients; only "real-world" data collected by administrative databases are available in the context of nutrition in oncology, and this somehow limits the possibility to interpret the evidence from a clinical point of view. Hence, the purpose of the intestigators is to collect "real world" clinical data on malnutrition in oncology at the national level, in order to strengthen the evidence and concretely improve nutritional care practices in oncology.

+Arms and interventions

ArmTypeInterventionsDescription
Cohort observationalOther: Cohort observationalOverall study cohort
  • Cohort observational (Other): Cohort observational

+Outcome measures

Primary outcomes

  • Overall survival [1 year]: Percentage of patients who are alive.

Secondary outcomes

  • Progression-free survival [1 year and 2 years]: Percentage of patients who are free from tumor progression.
  • Treatment toxicity [1 year]: Treatment-related severe adverse event (grade > or =3) according to Common Terminology Criteria for Adverse Events (CTCAE v5.0) and toxicity resulting in any treatment delay or dose reduction.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Aged ≥18 years;
* New diagnosis of the following cancers: head and neck, oesophagus/stomach, colorectal, hepato-biliary, pancreatic, lung, prostate, other urogenital, breast, gynaecological and, soft tissue sarcomas and melanomas; patients with a new diagnosis of metastatic disease will be also included;
* Eligible for active treatment;
* Written informed consent to participate in the study.

Exclusion Criteria:

* Impossibility to undertake the expected measurements;
* Impossibility to guarantee the attendance of the follow-up visits.

+Locations (16)

FacilityCityCountryStatus
IRCCS Istituto Tumori Giovanni Paolo II,Bari, BAItalyNot yet recruiting
IRCCS Saverio De BellisCastellana Grotte, BAItalyRecruiting
Istituto Ortopedico RizzoliBologna, BOItalyRecruiting
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRCCSMeldola, FCItalyRecruiting
IRCCS Ospedale Policlinico San MartinoGenova, GEItalyNot yet recruiting
IRCCS Ospedale San Raffaele, MilanoMilan, MIItalyRecruiting
Centro di Riferimento OncologicoAviano, PNItalyRecruiting
IOV Istituto Oncologico VenetoPadova, PVItalyRecruiting
AUSL IRCCS Reggio-EmiliaReggio Emilia, REItalyRecruiting
IDI IRCCS - Istituto Dermopatico dell'ImmacolataRoma, RMItalyRecruiting
Istituto Nazionale Tumori Regina ElenaRoma, RMItalyRecruiting
Policlinico Universitario Agostino GemelliRoma, RMItalyRecruiting
Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia - IRCCSCandiolo, TOItalyRecruiting
IRCCS Sacro Cuore Don CalabriaNegrar, VRItalyRecruiting
Istituto Nazionale Tumori IRCCS Fondazione G. PascaleNaplesItalyNot yet recruiting
Fondazione IRCCS Policlinico San Matteo, PaviaPaviaItalyRecruiting

+Publications

  • Caccialanza R, De Lorenzo F, Gianotti L, Zagonel V, Gavazzi C, Farina G, Cotogni P, Cinieri S, Cereda E, Marchetti P, Nardi M, Iannelli E, Santangelo C, Traclo F, Pinto C, Pedrazzoli P. Nutritional support for cancer patients: still a neglected right? Support Care Cancer. 2017 Oct;25(10):3001-3004. doi: 10.1007/s00520-017-3826-1. Epub 2017 Jul 14. No abstract available. PMID 28710645
  • Caccialanza R, Goldwasser F, Marschal O, Ottery F, Schiefke I, Tilleul P, Zalcman G, Pedrazzoli P. Unmet needs in clinical nutrition in oncology: a multinational analysis of real-world evidence. Ther Adv Med Oncol. 2020 Feb 14;12:1758835919899852. doi: 10.1177/1758835919899852. eCollection 2020. PMID 32110247
  • Pedrazzoli P, Caccialanza R, Cotogni P, Degli Esposti L, Perrone V, Sangiorgi D, Di Costanzo F, Gavazzi C, Santoro A, Pinto C. The Advantages of Clinical Nutrition Use in Oncologic Patients in Italy: Real World Insights. Healthcare (Basel). 2020 May 6;8(2):125. doi: 10.3390/healthcare8020125. PMID 32384639

My Notes